组蛋白去乙酰化酶抑制剂抗肿瘤作用机制研究进展
被引量：3
摘要
组蛋白去乙酰化酶抑制剂可通过阻滞细胞周期、诱导细胞凋亡、抑制血管新生、诱导自我吞噬等多种途径发挥抗肿瘤作用。此外,与其他抗肿瘤化合物联合应用时也表现出良好的抗肿瘤活性,具有极大的临床开发潜力。
出处
《中国医药指南》
2011年第6期47-48,共2页
Guide of China Medicine
基金
国家自然科学基金资助项目(30772645
30873137)
参考文献6
-
1Stimson L,Nicholas B,La Thangue.Biomarkers for predicting clinical responses to HDAC inhibitors[J].Cancer Lett,2009,280(2):177-183.
-
2Noh EJ,Lim DS,Jeong G,et al.An HDAC inhibitor,trichostatin A,induce a delay at G2/M transition,slippage of spindle checkpoint,and cell death in a transcription-dependant manner[J].Biochem Biophy Res Commun,2009,378(3):326-331.
-
3Park SJ,Kim MJ,Kim HB,et al.Triehostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by downregulation of c-FLIPL via inhibition of EGFR pathway[J].Bioehem Pharmacol,2009,77(8):1328-1336.
-
4Kwon HJ,Kim MS,Kim MJ,et al.HISTONE DEACETYLASE INHIBITOR FK228 INHIBITS TUMOR ANGIOGENESIS[J].Int J Cancer,2002,97(3):290-296.
-
5Qi C,Chuanfei Y,Ruiqi X,et al.Autophagy induced by suberoylanilidc hydroxamic acid in Hela S3 cells involves inhibition of protein kinase B and up-regulation of Beclin l[J].hat J Biochem Cell Biol,2008,40(2):272-283.
-
6Lee CK,Shuiliang W,Xiaoping H,et al.HDAC inhibition synergistically enhances alkylator-induced DNA damage response and apotosis in multiple myeloma cells[J].Cancer Lett,2010,296(2):233-240.
同被引文献60
-
1李晓晖,李建勋,李世荣,修志龙,西野宪和.环肽类组蛋白去乙酰化酶抑制剂[J].化学进展,2007,19(5):762-768. 被引量：7
-
2Mauro MJ. Defining and managing imatinib resistance. Hematology Am Soc Hematol Educ Program, 2006, 1 : 219-225.
-
3Meggyesi N, Kozma A, Halm G, et al. Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and Clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients. Acta Haematol, 2012, 127:34-42.
-
4Leder K, Foo J, Skaggs B, et al. Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia. PLoS One, 2011; 6:e27682.
-
5Hochhaus A, Kreil S, Corbin AS, et al. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia, 2002: 16:2190-2196.
-
6Seca H, Lima RT, Guimaraes JE, et al. Simultaneous targeting of P-gp and XIAP with siRNAs increases sensitivity of P-gp overexpressing CML cells to imatinib. Hematology, 2011, 16:100-107.
-
7Brendel C, Scharenberg C, Dohse M, et al. Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells. Leukemia, 2007, 21:1267-1275.
-
8Bellodi C, Lidonnici MR, Hamilton A, et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells including primary CML stem cells. J Clin Invest, 2009, 119:1109-1123.
-
9Bruno C, Salomoni P. Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors. Leuk Lymphoma, 2011, 52:54-59.
-
10Pene-Dumitrescu T, Smithgall TE. Expression of a Src family kinase in chronic myelogenous leukemia cells induces resistance to Imatinib in a kinase-dependent manner. JBiol Chem, 2010, 285:21446-21457.
引证文献3
-
1王彦,冯文莉.伊马替尼治疗慢性粒细胞白血病的耐药机制与对策[J].生命的化学,2013,33(4):407-412. 被引量：4
-
2张玉娟,苏专专,王立辉,郑洪丽,杨静玉,陈国良.蓓萨罗汀衍生物的合成及其抗肿瘤活性研究[J].中国药物化学杂志,2014,24(3):183-187.
-
3梅亚君,秦永平,章丽,南峰,向瑾,余勤,梁茂植.高效液相色谱-串联质谱法测定人血清中伏立诺他及其M2代谢物浓度[J].华西医学,2016,31(2):278-282. 被引量：1
二级引证文献5
-
1朱玉峰,王元占,孟凡义.P210^T315I-BCR/ABL转基因小鼠模型的建立与鉴定[J].中华血液学杂志,2015,36(3):221-224.
-
2张杨,闫振宇,陈乃耀.对伊马替尼耐药的慢性髓细胞白血病的诊治进展[J].中国煤炭工业医学杂志,2015,18(6):1050-1054. 被引量：2
-
3闫艳,彭慧敏,王智.甲磺酸伊马替尼治疗慢性粒细胞白血病发生严重剥脱性皮炎一例[J].白血病．淋巴瘤,2015,24(8):504-504.
-
4苗玉迪,魏绪仓.达沙替尼联合氟达拉滨对慢粒K562细胞的抑制作用研究[J].现代检验医学杂志,2015,30(5):70-72. 被引量：1
-
5张馨予,颜月园,刘刚,胡玉涛.LC-MS/MS法同时测定大鼠血浆中来那度胺、伏立诺他和地塞米松的浓度[J].南京医科大学学报（自然科学版）,2022,42(9):1240-1245.
-
1Quan Liu Jianjun Wang Yongcheng Pan Lifeng Meng Xi Zhan.Expression of Beclin1 in non small cell lung cancer and its clinical significance[J].Journal of Nanjing Medical University,2008,22(2):121-124. 被引量：6
-
2孙公甲.抑制血管新生治疗癌症[J].科技信息（吉林）,1991(6):25-26.
-
3朱翠敏,赵立双,赵蕾,田文亮,张志华,郝长来.丙戊酸钠对Kasumi-1细胞VEGF、bFGF表达的影响[J].山东医药,2009,49(15):14-15.
-
4楚荷莹,白勇,杨睿,陈闪闪,程瑞瑞,张国俊.恩度联合顺铂对老年晚期非小细胞肺癌患者血清MMP-2和VEGF水平的影响[J].肿瘤基础与临床,2014,27(4):300-301. 被引量：21
-
5姚峰,王冠楠,李娟娟,涂毅,魏文,童鹤翔,孙圣荣.1,6二磷酸果糖增强蛋白酶体抑制剂对人乳腺癌细胞MCF-7的抑瘤效应[J].肿瘤防治研究,2011,38(12):1360-1362.
-
6许长青,刘丹,郭喆.复方斑蝥胶囊抑制血管新生的体内体外研究[J].新中医,2015,47(11):211-213. 被引量：5
-
7苏东晓,张爱联,屈直.血管生成抑制因子抗癌研究进展[J].海南大学学报（自然科学版）,2009,27(3):297-301.
-
8蒋晓明,李晓红.羟基喜树碱膀胱内灌注预防膀胱浅表肿瘤复发[J].海峡药学,1997,9(S1):67-67.
-
9徐益明,金美玲.血管内皮生长因子及其受体与非小细胞肺癌血管新生[J].国际呼吸杂志,2008,28(18):1132-1135. 被引量：1
-
10顾建建,纪钧.VEGF及其在肺癌抗血管生成中的研究进展[J].实用肿瘤杂志,2009,24(6):614-616. 被引量：2
